For more than a month, Italy is experiencing an unprecedented situation: stores are closed, productivity has stopped, restaurants and aperitivi are distant memories that seem to belong to a different lifetime. The whole country has been put under forced quarantine since March 10 to stop the surge in coronavirus cases that is threatening the nationa...

Wednesday, April 29, 2020. 5:30 PM – 7:00 PM PDT. register here. Dear ISSNAF BAC members and friends, in these difficult times, the sense of community and familiar faces provide a feeling of comfort. In this spirit, we would like to continue bringing together the community of Italian scholars and scientists in the Bay Area. In the last two years, B...

An Anglo-Italian partnership is on the frontline in the development of a coronavirus vaccine, which could be ready in September, researchers said. The venture brings together Italian company Advent-IRBM -- based in the city of Pomezia, south of Rome -- and the Jenner Institute of the University of Oxford. The team has accelerated human testing of t...

Four days before the first cases of COVID-19 were confirmed in Italy on January 31, a small biotech firm in the outskirts of Rome announced it was pivoting its business. Researchers at Takis Biotech, which had been focused on cancer treatments, would instead set about developing a vaccine for the rapidly spreading coronavirus. With the virus now ra...

The 2020 edition of Italian Research Day in the World, celebrated on April 15, the anniversary of the birth of Leonardo Da Vinci, falls at a crucial historical moment, when Italy and the whole world are confronted with the COVID-19 pandemic. The Italian Research Day in the World allows reflecting on the importance of scientific collaboration in the...

The Barilla family, which owns the pasta maker of the same name, has donated $500,000 to U.S. non-profit association "The Cure Alliance" to fund research on a COVID-19 therapy based on stem cells, the group said on Monday. The clinical trial for the cure, which is being developed by a group of international scientists led by Italian professor Camil...

Researchers at the University of Pittsburgh School of Medicine report initial success in animal trials for a vaccine to neutralize the virus that causes COVID-19. During tests in mice, the vaccine was shown to produce antibodies specific to SARS-CoV-2, known as the novel coronavirus. University researchers said the mice responded with antibodies su...

A group of Italian biotech companies has recently entered the world race to contain and finally defeat the coronavirus, and are getting results. While the chronicles are full of Japanese miracle drugs and vaccine trials in the four corners of the world, Italian biotech is getting international recognition and is close to important trials. “Perhaps...

Vò, near Venice, was one of the 11 towns and villages at the centre of the country's COVID-19 outbreak and began the trial at the start of the pandemic in Europe. The experiment involved blanket testing of the town's entire population of 3,300 people and the imposition of very strict quarantine on those infected and their contacts. Italian news rep...

Within a week, preclinical tests of the new coronavirus vaccine developed by Takis, a biotechnology company based on a fragment of virus genetic material, will begin in Italy. They will test the vaccine in animals. She reported on Wednesday the Italian ANSA with the approval of preclinical testing Italian Ministry of Health. Initial laboratory t...